Dih Holdings US Inc logo

Dih Holdings US Inc (DHAI)

Market Closed
15 Jun, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
837 Market Cap
- P/E Ratio
- Div Yield
5,996 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 9
Want to track DHAI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DHAI closed yesterday higher at $0, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, DHAI stock lost -87.5%.
DHAI is not paying dividends to its shareholders.
Dih Holdings US Inc has completed 1 stock splits, with the recent split occurring on Oct 20, 2025.
The company's stock is traded on one exchange.

DHAI Chart

Dih Holdings US Inc (DHAI) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Dih Holdings US Inc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is DHAI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 837.

Has Dih Holdings US Inc ever had a stock split?

Dih Holdings US Inc had 1 splits and the recent split was on Oct 20, 2025.

Dih Holdings US Inc Profile

Diversified Consumer Services Industry
Consumer Discretionary Sector
Lynden Bass CEO
OTC PINK Exchange
23290B205 CUSIP
US Country
178 Employees
- Last Dividend
20 Oct 2025 Last Split
- IPO Date

Overview

DIH Holding US, Inc., established in 2021 and headquartered in Norwell, Massachusetts, stands at the forefront of the rehabilitation industry, providing cutting-edge robotics and virtual reality (VR) technologies across Europe, the Middle East, Africa, the United States, and the Asia Pacific. The company is dedicated to enhancing rehabilitation processes through innovative solutions designed to meet the needs of patients at different stages of recovery. Its focus spans the development and distribution of both upper and lower extremity rehabilitation products, leveraging the power of robotics and VR to facilitate effective, patient-centric therapy strategies.

Products and Services

ArmeoPower: A robotic system targeting early-stage rehabilitation to aid arm and hand therapy, enabling patients to engage in self-initiated, repetitive movements.

ArmeoSpring: Designed for patients with less severe impairments, this tool supports self-initiated arm and hand therapy across an extensive workspace, aimed at enhancing recovery.

ArmeoSpring Pro: An advanced version of ArmeoSpring, offering additional features and capabilities for a more comprehensive rehabilitation experience.

Armeo Senso: Suitable for patients requiring assistance with self-initiated but structurally controlled movements, this device focuses on improving motor skills through open movement exercises.

Erigo: Focused on early-stage rehabilitation, Erigo assists with verticalization and leg mobilization while providing intensive sensorimotor stimulation through cyclic leg loading.

Lokomat: A robot-assisted therapy platform designed to strengthen muscles and increase the range of motion in joints, thereby improving the ability to walk.

Andago: A mobile robotic system that supports natural walking, helping patients regain their gait through smart control technology.

C-Mill: Offers a unique training environment that simulates real-life challenges, aiding in the improvement of gait and balance.

CAREN: A computer-assisted rehabilitation environment that provides an immersive VR setup for comprehensive rehabilitation training and assessment.

GRAIL: Stands for Gait Real-time Analysis Interactive Lab, offering an advanced solution for gait analysis, training, and research through interactive technologies.

SafeGait, RYSEN, and M-Gait: A series of products focusing on gait and balance, providing diversified solutions ranging from balance enhancement to comprehensive gait training systems.

HocoNet and D-Flow software: Software solutions designed to work seamlessly with DIH’s hardware products, offering user-friendly interfaces for therapy planning, execution, and progress monitoring.

Contact Information

Address: 77 Accord Park Drive
Phone: 617 871 2101